AIMMUNE THERAPEUTICS, INC.

• BRISBANE, CA How do I update this listing?

Aimmune Therapeutics is based out of Brisbane. Aimmune Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing treatments to protect children with food allergies from accidental exposure. Aimmune Therapeutics serves customers worldwide.Whalewisdom has at least 76 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-11-29. The notice included securities offered of Equity

Create Alert

Contact Info

aimmune therapeutics, inc.
8000 MARINA BOULEVARD
BRISBANE CA    94005-1884
Business Phone: (650) 614-5220
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-11-29 D OTHER HEALTH CARE Equity 98,000,002 98,000,002 0
2018-03-16 D OTHER HEALTH CARE Equity 156,700,012 156,700,012 0
2015-03-24 D OTHER HEALTH CARE Equity,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 80,000,002 80,000,002 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BRETT K. HAUMANN subscription required
    DIRECTOR
BRYAN L. WALSER subscription required
    DIRECTOR
DANIEL C. ADELMAN subscription required
    EXECUTIVE OFFICER
DOUGLAS T. SHEEHY subscription required
    EXECUTIVE OFFICER
ERIC H. BJERKHOLT subscription required
    EXECUTIVE OFFICER
GREGORY BEHAR subscription required
    DIRECTOR
JAMES TANANBAUM subscription required
    DIRECTOR
JAYSON D.A. DALLAS subscription required
    EXECUTIVE OFFICER DIRECTOR
JEFFREY H. KNAPP subscription required
    EXECUTIVE OFFICER
JOONKYOO (ANTHONY) YUN subscription required
    DIRECTOR
KATHRYN E. FALBERG subscription required
    DIRECTOR
MARK T. IWICKI subscription required
    DIRECTOR
MARK D. MCDADE subscription required
    DIRECTOR
MARY M. ROZENMAN subscription required
    EXECUTIVE OFFICER
PATRICK ENRIGHT subscription required
    DIRECTOR
STACEY D. SELTZER subscription required
    DIRECTOR
STEPHEN G. DILLY, JR. subscription required
    EXECUTIVE OFFICER DIRECTOR
SUSAN E. BARROWCLIFFE subscription required
    EXECUTIVE OFFICER
VICTOR COLUNGA subscription required
    EXECUTIVE OFFICER

Elevate your investments